Yang Y, Yang W, Wang T J
Department of Radiation Oncology, The Second Hospital of Jilin University, Changchun, P.R. China
Department of Geriatric, The Second Hospital of Jilin University, Changchun, P.R. China
J Biol Regul Homeost Agents. 2017;31(3):631-637.
Radiotherapy (RT) is often the first choice of treatment for cancer of the larynx. Studies have shown that the incidence of carotid stenosis (CS) after radiotherapy of laryngeal cancer is increasing, and that gender difference in radiotherapy-induced side effects exist. Thus, we examined the gender difference in the incidence of CS and the impact of microinflammatory factors after radiotherapy. We reported this study on patients who received radiotherapy as part of the treatment for laryngeal cancer in the Jilin Province in China. One hundred sixty-four males and 152 females were treated with radiotherapy between 2006 and 2016. The carotid diameter was determined by measuring carotid intima-media thickness in the common, external and internal carotid artery. Microinflammatory conditions were assessed by measuring the level of high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). Other studied risk factors included age, treatment modalities, radiation dose and energy, the height of the radiation field, and the follow-up time. CS was detected in 161 (50.9%) of the 316 patients. Carotid stenosis was mainly clinically unsuspected, two patients had anamnesis of unconsciousness. Importantly, fewer women (36.1%) had CS than men (64.6%) (p=0.004). Furthermore, male patients showed higher serum levels of hs-CRP, IL-6, and TNF-α. Taken together, our study suggested that women underoing radiotherapy of laryngeal cancer are less likely to have CS than men. Therefore, routine assessment after irradiation of laryngeal cancer seems necessary for clinical detection of asymptomatic CS, particularly in male patients.
放射治疗(RT)通常是喉癌治疗的首选。研究表明,喉癌放疗后颈动脉狭窄(CS)的发生率在增加,且放疗引起的副作用存在性别差异。因此,我们研究了CS发生率的性别差异以及放疗后微炎症因子的影响。我们报告了这项针对中国吉林省接受放射治疗作为喉癌治疗一部分的患者的研究。2006年至2016年间,164名男性和152名女性接受了放射治疗。通过测量颈总动脉、颈外动脉和颈内动脉的颈动脉内膜中层厚度来确定颈动脉直径。通过测量高敏C反应蛋白(hs-CRP)、白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)水平来评估微炎症状态。其他研究的危险因素包括年龄、治疗方式、辐射剂量和能量、辐射野高度以及随访时间。316例患者中有161例(50.9%)检测到CS。颈动脉狭窄主要在临床上未被怀疑,2例患者有昏迷病史。重要的是,发生CS的女性(36.1%)比男性(64.6%)少(p=0.004)。此外,男性患者的hs-CRP、IL-6和TNF-α血清水平较高。综上所述,我们的研究表明,接受喉癌放疗的女性比男性发生CS的可能性更小。因此,对于无症状CS的临床检测,喉癌放疗后进行常规评估似乎是必要的,尤其是在男性患者中。